News

IO Biotech's Leadership to Showcase Innovations at Major Conferences

IO Biotech's Leadership to Showcase Innovations at Major Conferences

IO Biotech's Conference Participation Overview

IO Biotech, a leading clinical-stage biopharmaceutical company, is making strides in the cancer treatment landscape with its innovative immune-modulatory therapeutic vaccines. The company's participation in prominent conferences underscores its commitment to sharing advancements and insights within the oncology sector.

Fireside Chat at Cowen Oncology Summit

At the upcoming TD Cowen 6th Annual Oncology Summit, scheduled for May 27-28, 2025, Mai-Britt Zocca, PhD, President and CEO of IO Biotech, will engage in a fireside chat alongside Amy Sullivan, CFO, and Qasim Ahmad, MD, CMO. This engaging dialogue aims to offer insights into the company’s innovative approach to developing therapeutic cancer vaccines, bolstering confidence among investors and stakeholders about the future of cancer immunotherapy.

Session Details

The fireside chat is set for Tuesday, May 27, 2025, at 10:30 AM EST. Attendees can listen to the discussion through a live webcast, making this event accessible to a broader audience interested in oncology advancements.

Presentation at Jefferies Global Healthcare Conference

In addition to the Cowen Summit, the team from IO Biotech will also showcase their groundbreaking work at the Jefferies Global Healthcare Conference from June 3-5, 2025. Dr. Zocca will present the latest updates on IO Biotech's clinical pipeline, specifically focusing on Cylembio and other promising candidates under development.

Key Presentation Information

Scheduled for June 4, 2025, at 7:35 AM EST, Dr. Zocca's presentation will delve into the company’s innovative therapies and ongoing clinical trials. Participants will have the opportunity to engage in one-on-one meetings to discuss potential investment opportunities and the future of IO Biotech's research endeavors.

Understanding Cylembio®: A Transformative Approach

Cylembio® represents a pivotal advancement in the field of cancer therapy. It is designed to eradicate both cancerous and immunosuppressive cells within the tumor microenvironment by recruiting and activating T cells against specific cellular targets such as IDO1 and PD-L1. This strategic immunotherapy aims to enhance patient outcomes significantly.

Clinical Trials and Collaborations

Currently, IO Biotech is in the midst of conducting several critical clinical trials for Cylembio. The pivotal Phase 3 trial, along with multiple Phase 2 studies, investigates its efficacy in conjunction with Merck’s anti-PD-1 therapy, KEYTRUDA®. The company not only maintains full global commercial rights to Cylembio but is also collaborating with Merck in these studies, ensuring that patients receive leading-edge treatment options.

About IO Biotech

Headquartered in Copenhagen, Denmark, with a presence in New York, IO Biotech is at the forefront of developing novel cancer vaccines. Their T-win® platform represents a sophisticated method of activating T cells to combat tumor cells effectively. As they move forward with additional clinical trials, the company is set on expanding its pipeline and enhancing its therapeutic offerings.

Contact Information

For more inquiries, stakeholders can reach out to:

Investors
Maryann Cimino, Director of Investor Relations
IO Biotech, Inc.
617-710-7305
mci@iobiotech.com

Media
Julie Funesti
Edelman
917-498-1967
julie.funesti@edelman.com

Frequently Asked Questions

What is Cylembio®?

Cylembio® is an investigational therapeutic cancer vaccine designed to stimulate T cells and target both tumor and immunosuppressive cells.

Who will be participating in the Cowen Oncology Summit?

Mai-Britt Zocca, PhD, Amy Sullivan, CFO, and Qasim Ahmad, MD, CMO from IO Biotech will participate in the fireside chat.

What is the significance of the Jefferies Global Healthcare Conference?

This conference provides a platform for IO Biotech to present their latest research findings and engage with potential investors.

How can I access the conference webcasts?

Webcasts for both events will be made available on the Investors section of IO Biotech's website following the conferences.

How does IO Biotech's research impact cancer treatment?

IO Biotech's innovative approach to cancer vaccines aims to enhance patient outcomes by effectively activating the immune response against tumors.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

NACD Honors Top Board Leaders with 2026 Awards

Updated Category News Views 10

Celebrating Boardroom Mavericks at NACD Gala September 2026 has brought some sparkling recognition to the elites guiding today's corporate governance landscapes. The National Association of Corporate Directors (NACD) has announced their Directorship 100 honorees, tipping their hats to stellar individuals firing on all cylinders in the boardroom. Who's Getting the Nod?...

Continue Reading
HNTB Expands in Capital Region: A Strategic Move

Updated Category News Views 1

Breaking New Ground in Arlington and Baltimore Deepening their stake in the Capital Region's future, HNTB has thrown open new office doors in Arlington, Virginia, and Baltimore, Maryland. We're not just talking fancy buildings, folks—this is about securing a piece of the infrastructure pie that's only going to get bigger and tastier. Infrastructure's the backbone of...

Continue Reading
Nature-Based Solutions: The Economic And Community Impact

Updated Category News Views 6

Harnessing Nature to Boost Economies You ever stop to think about how nature itself might just be the best investment? Well, the Walton Family Foundation surely does, betting big on nature-based solutions. Their latest initiative, 'Human Nature,' is shedding light on how these solutions aren't just saving ecosystems — they're fortifying economies and enriching...

Continue Reading
Annex Brands Grows with Bastrop's PostalAnnex Opening

Updated Category News Views 1

New PostalAnnex Location Opens in Bastrop, TX Here's a fresh chapter in the books for Annex Brands, Inc. They've just cut the ribbon on a brand spanking new PostalAnnex in Bastrop, Texas, handing the reins over to eager fresh faces, Chetan Modi and Karan Desai. And you know what? This ain't just any regular location. It's a one-stop-shop for anything you could need, from...

Continue Reading
Anixa Expands Global Footprint with Aussie Patent

Updated Category News Views 3

Breaking New Ground in Cancer Immunotherapy Today feels like a pivotal day for Anixa Biosciences. Their announcement about securing a patent in Australia for their trailblazing breast cancer vaccine is like planting a flag on new, promising territory. This is no minor step; it's a strategic leap for the company as it strengthens its intellectual grip on the global...

Continue Reading
Navigating AI's New Era: Dresner's 2026 Findings

Updated Category News Views 5

Big Insights in the AI World of 2026 Well folks, if there's one thing making waves in the boardrooms this year, it's AI. Dresner Advisory Services just threw down a gauntlet for companies with their fresh batch of reports focused on the dizzying world of AI. They ripped right into it, exploring how firms can bag a heap of benefits and deal with the hurdles that come with...

Continue Reading
Lavior and CR Fitness Team for Wellness Reach

Updated Category News Views 2

Botanical Care Meets Gym Life in the Southeast Lavior, the botanical whiz kids of wound and skin care out of Miami, are shaking hands with CR Fitness, Crunch's big-time franchise operator carrying the flag across the Southeast. They’ve ironed out a deal that’ll park Lavior’s products in more than 60 gyms covering Florida, Georgia, North Carolina, and Texas. It’s a...

Continue Reading
Molex's VersaBeam Mini Pushes AI Data Center Limits

Updated Category News Views 2

Game-Changer for AI Data Centers? Across the tech landscape, space is a premium, and Molex's new VersaBeam Mini arrives like a hail Mary in the fourth quarter. In AI data centers, squeezing down every single component counts—especially when optical density's in play. What we're seeing here is a potential paradigm shift. A 3x density improvement from a tiny 3.5 x 9 mm...

Continue Reading
Lawsuit Targets Electrical Consultants' Labor Practices

Updated Category News Views 3

Trouble Brews at Electrical Consultants, Inc. Right on the heels of a long workday, some employees of Electrical Consultants, Inc. seem to be getting a double whammy. The company is tangled up in a class action lawsuit lodged by the well-known Blumenthal Nordrehaug Bhowmik De Blouw LLP. This ain't your everyday grievance, folks; we're talking meal and rest period...

Continue Reading
Spencer Peterman Hosts Eco-Friendly Wood Bowl Sale

Updated Category News Views 3

Just when you think you've seen it all in the world of craftsmanship, along comes a dynamo like Spencer Peterman. For over 25 years, he's been turning what others discard into treasures. Fallen trees? Most folks see firewood. Spencer sees a future masterpiece. And now, he’s rolling out the welcome mat for his loyal customers with a special sale that runs until December...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Dell Technologies' Robust Options Activity Insights

Updated Category News Views 87

Understanding Recent Investor Behavior in Dell Technologies Investors with substantial resources have taken a notably bullish stance towards Dell Technologies (NASDAQ: DELL). This shift in sentiment is crucial and signals to market participants that they should pay close attention. Tracking unusual activities through option records has revealed this critical trend,...

Continue Reading
Compass Diversified Faces Class Action Amid Accounting Irregularities

Updated Category News Views 221

Compass Diversified's Recent Challenges Compass Diversified (NYSE: CODI) has recently made headlines due to serious accounting irregularities that have raised concerns among its investors. The Connecticut-based private equity firm filed a report with the SEC that warned stakeholders not to rely on certain financial statements from its recent fiscal years, particularly...

Continue Reading
Kojamo Announces Sale of 44 Residential Properties for EUR 242M

Updated Category News Views 183

Kojamo Enters Agreement to Sell Residential Properties Kojamo plc has taken a significant step by agreeing to sell 44 rental housing properties to funds managed by Apollo and Avant Capital Partners for a total amount of EUR 242 million. This decision marks a strategic move within Kojamo's investment strategy, demonstrating its commitment to evolving its portfolio. Details...

Continue Reading
Phunware Introduces Innovative Mobile Event Solutions

Updated Category News Views 40

Phunware Showcases Advanced Mobile Solutions at Major Expos Phunware, Inc. (NASDAQ: PHUN), a prominent leader in enterprise cloud solutions for mobile applications, is set to unveil its customizable mobile solutions tailored for event management. The company will be present at significant trade shows, demonstrating the capabilities of their solutions designed specifically...

Continue Reading
A Deep Dive into Fiserv, Inc.'s Legal Challenges and Investor Rights

Updated Category News Views 472

Understanding Fiserv, Inc.'s Current Legal Issues With the landscape of securities litigation ever-evolving, Fiserv, Inc. has become a focal point for investor concerns. This well-known technology provider, significantly impacting financial services, finds itself navigating a challenging legal environment that is crucial for its investors to comprehend. What is the...

Continue Reading